There's mixed interest in biotech, biopharmaceutical and emerging pharma companies.
US market are set for a lower open following weak data from China and ongoing concern Italians will have to go for another round of elections.
The two companies face problems with their weight-loss drugs.
The month also features a big gathering of biotech CEOs in New York and a cancer research meeting in Florida.
Stocks are mixed on the first day of a compressed and very busy week for earnings.
TheStreet's Adam Feuerstein gazes into his crystal ball to offer his biotechnology forecast for the new year.
Look to these high-flying stocks for ideas for 2013.
VIDEO ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Andrew Mason's new Detour could be one of the most-watched comeback attempts in recent Silicon Valley history.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
PCs and travel are hot, big-screen TVs and Apple aren't so much, in our August Buying Guide.
Six weeks later, most Americans have forgotten about the 2014 tax season -- except those who didn't file by the April 15 deadline.
MUST-SEE ON MSN
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'